Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elan's controlled-release OTCs

Executive Summary

Irish firm announces availability of following sustained-release OTC products for licensing -- Asprilan 12-hour aspirin tablets; Parelan 8-12 hour acetaminophen suspension; Elangesic twice-daily ibuprofen tablets; Elan-K potassium chloride suspension and tablets; "a range" of 12 and 24-hour cough/cold tablets containing a variety of ingredients singly and in combination; and Elan-PPA, a once-a-day appetite suppressant.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS013097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel